hi continue visiting your profile
do you want to Log Out ?

Signaling Pathways title  Inflammasome Signaling Pathway NLRP3, IL1B, CASP1 what else?

NLRP3 inflammasome is a multimeric cytosolic protein complex that assembles in response to cellular perturbations. This assembly leads to the activation of caspase-1, which promotes maturation and release of the inflammatory cytokines interleukin-1β (IL-1β) and IL-18, as well as inflammatory cell death (pyroptosis) (1).

Mechanism of NLRP3 inflammasome activation (1)

Signaling Pathways title  Inflammasome and diseases

NLRP3 inflammasome play dual roles in mediating human disease: inflammatory, metabolic (atherosclerosis, nonalcoholic fatty liver disease (NAFLD), gout, type 2 diabetes and obesity induced insulin resistance.), chronic neurodegenerative diseases, and COVID-19... Without ignoring their beneficial role in numerous infectious diseases and some cancers (1,3,4).
(1) Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. (2021);22(5):550-559.
(2) Paik S et al. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. (2021);18(5):1141-1160.
(3) Wang L, Hauenstein AV. The NLRP3 inflammasome: Mechanism of action, role in disease and therapies. Mol Aspects Med. (2020);76:100889.
(4) Zhao N, Di B, Xu LL. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev. (2021);61:2-15.
For more information on prices, click here